Order Article Reprints

Burmeister Y, Weyer K, Dörre A, Seilheimer B. The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis. Biomedicines. 2023; 11(12):3216. https://doi.org/10.3390/biomedicines11123216

Burmeister, Yvonne, Kathrin Weyer, Achim Dörre, and Bernd Seilheimer. 2023. "The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis" Biomedicines 11, no. 12: 3216. https://doi.org/10.3390/biomedicines11123216

Burmeister, Y., Weyer, K., Dörre, A., & Seilheimer, B. (2023). The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis. Biomedicines, 11(12), 3216. https://doi.org/10.3390/biomedicines11123216